Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.58 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.56 |
| ▸ | DRD2 | P14416 | 3/20 | 0.56 |
| ▸ | HTR7 | P34969 | 3/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | XBP1 | P17861 | 1/20 | 0.46 |
| ▸ | CTSV | O60911 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.45 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30290988 | 1.00 | IDO1 (0.58) | IDO1CHRM4DRD2HTR7FFAR1 | |
| SCHEMBL30908530 | 0.90 | IDO1 (0.56) | IDO1CHRM4DRD2HTR7FFAR1 | |
| SCHEMBL817976 | 0.90 | IDO1 (0.56) | IDO1CHRM4DRD2HTR7FFAR1 | |
| SCHEMBL28735117 | 0.87 | IDO1 (0.62) | IDO1HTTALDH1A1CTSVCTSL | |
| SCHEMBL18817861 | 0.85 | IDO1 (0.60) | IDO1FFAR1HTTALDH1A1CTSV | |
| SCHEMBL29733350 | 0.85 | IDO1 (0.53) | IDO1CHRM4DRD2HTR7FFAR1 | |
| SCHEMBL2190894 | 0.85 | IDO1 (0.53) | IDO1CHRM4DRD2HTR7FFAR1 | |
| SCHEMBL15412376 | 0.84 | IDO1 (0.58) | IDO1FFAR1HTTALDH1A1XBP1 | |
| SCHEMBL28016432 | 0.84 | IDO1 (0.63) | IDO1FFAR1HTTALDH1A1XBP1 | |
| SCHEMBL26419665 | 0.84 | IDO1 (0.58) | IDO1HTTALDH1A1CTSVCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4430657-A1 | PHOTOCHEMICAL AND THERMAL RELEASE LAYER PROCESSES AND USES IN DEVICE MANUFACTURING | Terecircuits Corporation (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023086403-A1 | PHOTOCHEMICAL AND THERMAL RELEASE LAYER PROCESSES AND USES IN DEVICE MANUFACTURING | TERECIRCUITS CORPORATION (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20230130004-A1 | RELEASE LAYER COMPOSITION FOR TRANSFER OF COMPONENTS | TERECIRCUITS CORPORATION | 2023-04-27 | — | — | US | disclosed |
| US-20230130004-A1 | RELEASE LAYER COMPOSITION FOR TRANSFER OF COMPONENTS | TERECIRCUITS CORPORATION | 2023-04-27 | — | — | US | disclosed |
| US-20160007606-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-01-14 | — | — | US | disclosed |
| US-20150065481-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-03-05 | — | — | US | disclosed |
| US-20150031541-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-01-29 | — | — | US | disclosed |
| US-7591943-B2 | desulfurization, denitrification and producing hydrocarbon oxidates by reacting with oxidant in presence of homogeneous oxidation catalyst and hydrobromide mixtures; gasoline with improved oxidant rating, cetane number | KOCAT INC. (KR) | 2009-09-22 | — | — | US | disclosed |
| US-7591943-B2 | desulfurization, denitrification and producing hydrocarbon oxidates by reacting with oxidant in presence of homogeneous oxidation catalyst and hydrobromide mixtures; gasoline with improved oxidant rating, cetane number | KOCAT INC. (KR) | 2009-09-22 | — | — | US | disclosed |
| US-7591943-B2 | desulfurization, denitrification and producing hydrocarbon oxidates by reacting with oxidant in presence of homogeneous oxidation catalyst and hydrobromide mixtures; gasoline with improved oxidant rating, cetane number | KOCAT INC. (KR) | 2009-09-22 | — | — | US | disclosed |
| US-20080121565-A1 | PROCESS FOR THE REDUCTION OF SULFUR, NITROGEN AND THE PRODUCTION OF USEFUL OXYGENATES FROM HYDROCARBON MATERIALS VIA ONE-POT SELECTIVE OXIDATION | KOCAT INC. (KR) | 2008-05-29 | — | — | US | disclosed |
| US-20080121565-A1 | PROCESS FOR THE REDUCTION OF SULFUR, NITROGEN AND THE PRODUCTION OF USEFUL OXYGENATES FROM HYDROCARBON MATERIALS VIA ONE-POT SELECTIVE OXIDATION | KOCAT INC. (KR) | 2008-05-29 | — | — | US | disclosed |
| US-20080121565-A1 | PROCESS FOR THE REDUCTION OF SULFUR, NITROGEN AND THE PRODUCTION OF USEFUL OXYGENATES FROM HYDROCARBON MATERIALS VIA ONE-POT SELECTIVE OXIDATION | KOCAT INC. (KR) | 2008-05-29 | — | — | US | disclosed |
| EP-1911830-A1 | Process for the reduction of sulfur, nitrogen and the production of useful oxygenates from hydrocarbon materials via one-pot selective oxidation | Kocat Inc. (KR) | 2008-04-16 | — | — | EP | disclosed |
| EP-1911830-A1 | Process for the reduction of sulfur, nitrogen and the production of useful oxygenates from hydrocarbon materials via one-pot selective oxidation | Kocat Inc. (KR) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160007606-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | PRF1, CASP1, MPO | IDO1 54/4885CHRM4 974/4885DRD2 1382/4885 |
| US-20150065481-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | PRF1, CASP1, MPO | IDO1 50/4885CHRM4 1200/4885DRD2 1512/4885 |
| US-20150031541-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | PRF1, CASP1, MPO | IDO1 54/4885CHRM4 974/4885DRD2 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.